SEC Filing Summary: ADVENTRX Pharmaceuticals, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by ADVENTRX Pharmaceuticals, Inc. on December 6, 2012. The filing discloses the adoption of a Change in Control Severance Plan by the Company's Compensation Committee. The report does not contain financial results for a specific reporting period, as it addresses a corporate governance event rather than periodic financial performance.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the terms of a new executive compensation plan. No financial statements are included in this specific report.
Material Changes
The primary material change reported is the establishment of the ADVENTRX Pharmaceuticals, Inc. Change in Control Severance Plan. Key provisions include:
- Eligibility: The plan covers certain officers, including Named Executive Officer Gregory D. Gorgas.
- Triggering Event: Benefits apply if employment terminates due to "Involuntary Termination" (without Cause or for Good Reason) within a window starting three months prior to and ending one year after a "Change in Control."
- Severance Benefits:
- A lump sum payment equal to six or nine months of the participant's annual base salary.
- A lump sum payment covering the estimated cost of continuing health care coverage for the participant and dependents for the same period.
- Specific Assignment: The Compensation Committee assigned a nine-month benefit period to Mr. Gorgas.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding business operations. The document defines specific risks and contingencies related to the severance plan, including:
- Definitions of Cause: Includes personal dishonesty for enrichment, felony convictions affecting reputation, willful misconduct, or continued willful violations of duties.
- Definitions of Good Reason: Includes material reduction of duties or salary, relocation of principal place of employment by more than 50 miles, or material breach of the Plan.
- Change in Control Thresholds: Defined as changes in Board majority, acquisition of 30% or more of voting power, certain mergers, or liquidation/sale of assets.
- Plan Termination: The Board may amend or terminate the Plan, but such changes cannot take effect earlier than 12 months after adoption without the written consent of the affected participant.
Investor Verification Checklist
- Verify the full text of the Change in Control Severance Plan attached as Exhibit 10.1 for complete legal terms.
- Confirm the current annual base salary of Gregory D. Gorgas to calculate the potential nine-month severance liability.
- Review the Company's proxy statement to identify all other officers designated as participants in the Plan.
- Monitor for any future amendments to the Plan, noting the 12-month restriction on termination without participant consent.